FMED Holdings — Fidelity Disruptive Medicine ETF
All 70 reported holdings of Fidelity Disruptive Medicine ETF (FMED) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Fidelity Revere Street Trust | 10.27% | $4.21M |
| Ucb SA | 4.73% | $1.94M |
| Lifestance Health Group, Inc. | 4.27% | $1.75M |
| Danaher Corp. | 3.42% | $1.40M |
| 10x Genomics, Inc. | 3.11% | $1.27M |
| Intuitive Surgical, Inc. | 2.92% | $1.20M |
| Cogent Biosciences, Inc. | 2.85% | $1.17M |
| Alnylam Pharmaceuticals, Inc. | 2.79% | $1.14M |
| Argenx SE | 2.78% | $1.14M |
| Legend Biotech Corp. | 2.29% | $940.12K |
| Unitedhealth Group, Inc. | 2.25% | $921.87K |
| Bio Techne Corp. | 2.24% | $919.18K |
| Ascendis Pharma A/s | 2.11% | $866.19K |
| Edwards Lifesciences Corp. | 2.11% | $864.70K |
| Moderna, Inc. | 2.11% | $862.73K |
| Kymera Therapeutics, Inc. | 1.99% | $814.20K |
| Xenon Pharmaceuticals, Inc. | 1.92% | $786.25K |
| Heartflow, Inc. | 1.89% | $774.31K |
| Sartorius Stedim Biotech | 1.84% | $754.70K |
| Insmed, Inc. | 1.79% | $735.01K |
| Veeva Sys, Inc. | 1.78% | $730.14K |
| Vaxcyte, Inc. | 1.76% | $723.25K |
| Revolution Medicines, Inc. | 1.73% | $709.29K |
| Caris Life Sciences, Inc. | 1.71% | $702.09K |
| Crinetics Pharmaceuticals, Inc. | 1.65% | $675.45K |
| Axsome Therapeutics, Inc. | 1.57% | $645.29K |
| Cytokinetics, Inc. | 1.55% | $634.19K |
| Veracyte, Inc. | 1.54% | $631.20K |
| Thermo Fisher Scientific, Inc. | 1.53% | $628.44K |
| Brightspring Health Services, Inc. | 1.53% | $628.33K |
| Privia Health Group, Inc. | 1.48% | $604.84K |
| Boston Scientific Corp. | 1.44% | $588.66K |
| Natera, Inc. | 1.43% | $584.11K |
| Kiniksa Pharmaceuticals International PLC | 1.42% | $580.56K |
| Guardant Health, Inc. | 1.38% | $567.39K |
| Stryker Corp. | 1.36% | $558.92K |
| Viridian Therapeutics, Inc. | 1.34% | $547.98K |
| Alignment Healthcare, Inc. | 1.25% | $511.35K |
| Lonza Group AG | 1.22% | $500.05K |
| Nuvalent, Inc. | 1.21% | $497.20K |
| Stoke Therapeutics, Inc. | 1.18% | $484.36K |
| Disc Medicine, Inc. | 1.18% | $481.84K |
| Dexcom, Inc. | 1.18% | $481.74K |
| Insulet Corp. | 1.10% | $451.05K |
| ELI LILLY and CO | 1.07% | $436.48K |
| Enliven Therapeutics, Inc. | 1.03% | $423.52K |
| Cytomx Therapeutics, Inc. | 0.98% | $403.45K |
| Waystar Holding Corp. | 0.98% | $401.92K |
| Irhythm Technologies, Inc. | 0.96% | $395.35K |
| Kestra Medical Technologies, Inc. | 0.95% | $391.18K |
| Newamsterdam Pharma Company NV | 0.91% | $374.59K |
| Amylyx Pharmaceuticals, Inc. | 0.82% | $338.00K |
| Roivant Sciences Ltd. | 0.82% | $337.39K |
| Align Technology, Inc. | 0.80% | $325.93K |
| Repligen Corp. | 0.75% | $308.02K |
| Zai Lab Ltd. | 0.66% | $270.18K |
| Mirum Pharmaceuticals, Inc. | 0.54% | $222.39K |
| Upstream Bio, Inc. | 0.51% | $208.16K |
| Relay Therapeutics, Inc. | 0.45% | $182.59K |
| Structure Therapeutics, Inc. | 0.44% | $182.07K |
| Zenas Biopharma, Inc. | 0.44% | $180.63K |
| Viking Therapeutics, Inc. | 0.43% | $177.52K |
| Procept Biorobotics Corp. | 0.43% | $175.25K |
| Janux Therapeutics, Inc. | 0.42% | $171.49K |
| Outset Medical, Inc. | 0.41% | $166.26K |
| Mbx Biosciences, Inc. | 0.39% | $161.38K |
| Olema Pharmaceuticals, Inc. | 0.36% | $148.39K |
| Fidelity Revere Street Trust | 0.29% | $118.67K |
| Oruka Therapeutics, Inc. | 0.14% | $58.53K |
| Spyre Therapeutics, Inc. | 0.05% | $22.05K |
FMED overview: performance, fees, allocation and SEC filings